The group sequential triangular test for phase II cancer clinical trials

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 19, Issue 4, 1996, Pages 422-430

  Bellissant, Eric ^a,c   Bénichou, Jacques ^b   Chastang, Claude ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b NATIONAL CANCER INSTITUTE   (United States)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Group sequential method; Oncology; Phase II noncomparative trials; Triangular Test

Indexed keywords

ANALYTIC METHOD; ARTICLE; CANCER RESEARCH; CLINICAL TRIAL; COMPUTER PROGRAM; DIAGNOSTIC TEST; DOSE RESPONSE; ETHICS; HUMAN; ONCOLOGY; PHASE 2 CLINICAL TRIAL;

ALGORITHMS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; DECISION MAKING; ETHICS, MEDICAL; HUMANS; LUNG NEOPLASMS; MODELS, STATISTICAL; NEOPLASMS; PROBABILITY; REMISSION INDUCTION; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; SOFTWARE DESIGN;

EID: 0029946536     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199608000-00021     Document Type: Article

References (25)

1. Carter SK. Clinical trials in cancer chemotherapy. Cancer 1977;40:544-57.
2. Williams CJ, Carter SK. Management of trials in the development of cancer chemotherapy. Br J Cancer 1978;37:434-47.
3. Herson J. Statistical aspects in the design and analysis of phase II clinical trials. In: Buyse ME, Staquet MJ, Sylvester RJ, eds. Cancer clinical trials: methods and practice. Oxford: Oxford Univ. Press, 1984:239-57.
4. Fleming TR. One-sample multiple testing procedure for phase II clinical trials. Biometrics 1982;38:143-51.
5. Gehan EA. The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chronic Dis 1961;13:346-53.
6. Herson J. Predictive probability early termination plans for phase II clinical trials. Biometrics 1979;35:775-83.
7. Lee YJ, Staquet M, Simon R, Catane R, Muggia F. Two-stage plans for patient accrual in phase II cancer clinical trials. Cancer Treat Rep 1979;63:1721-6.
8. Simon R. Optimal two-stage designs for phase II clinical trials. Controlled Clin Trials 1989;10:1-10.
9. Staquet M, Sylvester R. A decision theory approach to phase II clinical trials. Biomedicine 1977;26:262-6.
10. Sylvester RJ, Staquet MJ. An application of decision theory to phase II clinical trials in cancer. In: Tagnon HJ, Staquet MJ, eds. Recent advances in cancer treatment. New York: Raven, 1977:1-11.
11. Anderson TW. A modification of the sequential probability ratio test to reduce the sample size. Ann Math Stat 1960;31:165-97.
12. Wald A. Sequential analysis. New York: Wiley, 1947.
13. Bellissant E, Bénichou J, Chastang C. Application of the Triangular Test to phase II cancer clinical trials. Stat Med 1990;9: 907-17.
14. Jones DR, Newman CE, Whitehead J. The design of a sequential clinical trial for the comparison of two lung cancer treatments. Stat Med 1982;1:73-82.
15. Jones DR, Whitehead J. Sequential forms of the logrank and modified Wilcoxon tests for censored data. Biometrika 1979;66: 105-13.
16. Whitehead J. The design and analysis of sequential clinical trials. Chichester: Ellis Horwood, 1983.
17. Whitehead J. Jones DR. The analysis of sequential clinical trials. Biometrika 1979;66:443-52.
18. Whitehead J, Jones DR, Ellis SH. The analysis of a sequential clinical trial for the comparison of two lung cancer treatments. Stat Med 1983;2:183-90.
19. Whitehead J, Stratton I. Group sequential clinical trials with triangular continuation regions. Biometrics 1983;39:227-36.
20. Schoenfeld D. Statistical considerations for pilot studies. Int J Radiat Oncol Biol Phys 1980:6:371-4.
21. Whitehead J. Overrunning and underrunning in sequential clinical trials. Controlled Clin Trials 1992;13:106-21.
22. Whitehead J. Supplementary analysis at the conclusion of a sequential clinical trial. Biometrics 1986;42:461-71.
23. Whitehead J. On the bias of maximum likelihood estimation following a sequential test. Biometrika 1986;73:573-81.
24. Facey KM, Whitehead J. An improved approximation for calculation of confidence intervals after a sequential clinical trial. Stat Med 1990;9:1277-85.
25. Bellissant E, Bénichou J, Chastang C. A micro-computer program for the design and analysis of phase II cancer clinical trials with two group sequential methods, the sequential probability ratio test and the Triangular Test. Comput Biomed Res 1994;27: 13-26.